CPX-351 in Clinical Practice For AML

Video

Alexandra S. Wolff, PharmD, BCOP, comments on her experience with CPX-351 in clinical practice and the potential to combine CPX-351 with targeted agents for AML.

Related Videos
lymphoma, OPC, ASCO 2024, hodgkin lymphoma
MP Studio - stock.adobe.com
Image credit: David A Litman | stock.adobe.com
Credit: AkuAku - stock.adobe.com
Image credit: Halfpoint | stock.adobe.com
Credit: AkuAku - stock.adobe.com
Image Credit: © Mongta Studio - stock.adobe.com
Image credit: Halfpoint | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.